Company
harrison.ai
Builds clinical AI software that reads medical images and flags findings for clinicians. Its radiology products cover chest X-ray and non-contrast head CT (the company and press reporting cite up to 124 findings on chest X-ray and up to 130 on non-contrast head CT), with a separate pathology line aimed at slide review and workflow. The longevity relevance is earlier detection of disease at scale rather than any intervention on ageing biology: the software is deployed in over 1,000 healthcare facilities and is sold into radiology and pathology providers, including shareholder-linked networks Sonic Healthcare and I-MED Radiology. It does not develop drugs or therapeutics.
At a glance
- Listing
- Private, not listed
- Category
- Diagnostics
- Headquarters
- Sydney, New South Wales, Australia (Level P, 24 Campbell Street, Sydney NSW 2000)
- Market cap
- Not disclosed
Thesis
Why it is in this universe
- Category
- Diagnostics
- Market
- Australia
- Recent inflection
- On 29 January 2025 the Australian government's National Reconstruction Fund Corporation took a A$32m equity stake as part of harrison.ai's Series C, reported by ACS Information Age the same day; the company states more than US$240m raised to date.
- Services
- None recorded
- People tracked
- None on file
Market data
Listing and scale
| Metric | Detail |
|---|---|
| Exchange | Unlisted |
| Ticker | None |
| Secondary listing | None |
| Market cap | Not disclosed |
| Status | Private |
Editor's noteA listing or financing event is not a clinical result. variis grades evidence on the linked protocol, not the share price.
Get in touch
Contact
- Address
- Sydney, New South Wales, Australia (Level P, 24 Campbell Street, Sydney NSW 2000)
- Website
- harrison.ai
- Phone
- No public number published
- No public address published
Offering
What it sells today
No commercial services are recorded for this company yet.
Recent inflection
What moved lately
On 29 January 2025 the Australian government's National Reconstruction Fund Corporation took a A$32m equity stake as part of harrison.ai's Series C, reported by ACS Information Age the same day; the company states more than US$240m raised to date.
Common questions
- Why does variis track harrison.ai?
- Builds clinical AI software that reads medical images and flags findings for clinicians. Its radiology products cover chest X-ray and non-contrast head CT (the company and press reporting cite up to 124 findings on chest X-ray and up to 130 on non-contrast head CT), with a separate pathology line aimed at slide review and workflow. The longevity relevance is earlier detection of disease at scale rather than any intervention on ageing biology: the software is deployed in over 1,000 healthcare facilities and is sold into radiology and pathology providers, including shareholder-linked networks Sonic Healthcare and I-MED Radiology. It does not develop drugs or therapeutics.
- Is harrison.ai publicly listed?
- variis has no ticker on file for harrison.ai, so it is tracked as private or unlisted. Absence of a ticker on this record is not a statement that no listing exists anywhere.
- Where is harrison.ai based?
- Sydney, New South Wales, Australia (Level P, 24 Campbell Street, Sydney NSW 2000)
- Is harrison.ai still trading?
- harrison.ai is recorded as private.
Keep reading
Related coverage from the newsroom.
Sources
What this profile is built on
- About harrison.ai · harrison.ai
- Reconstruction Fund takes $32m stake in Harrison.ai · Information Age (Australian Computer Society)
- Harrison.ai investment page · National Reconstruction Fund Corporation
Every entity profile on variis is sourced. Not investment advice.